Galya Blachman
General Counsel bei 501 ACQU
Ursprung des Netzwerks ersten Grades von Galya Blachman
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
University of Cambridge
224
| College/University | Other Consumer Services | 224 |
University of Oxford
161
| College/University | Other Consumer Services | 161 |
University of Cape Town
108
| College/University | Other Consumer Services | 108 |
5AM Venture Management LLC
 5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US.
40
| Private Company | Investment Managers | 40 |
| Public Company | Biotechnology | 11 | |
BPP Law School
10
| College/University | Other Consumer Services | 10 |
7
| Private Company | Financial Conglomerates | 7 |
Stemcentrx, Inc.
 Stemcentrx, Inc. BiotechnologyHealth Technology Stemcentrx, Inc. develops life-changing therapies for cancer patients. It develops proprietary discovery platforms that yield unprecedented insight into the biology of tumors and are being exploited to develop potent new cancer drugs. The firm specializes in designing drugs to target cancer stem cells, which are the cells that cause cancer to spread throughout the body. The company was founded by Brian Christopher Slingerland, Daniel T. Reiner and Scott J. Dylla in 2008 and is headquartered in San Francisco, CA.
3
| Extinct | Biotechnology | 3 |
Biotech Connection-Bay Area, Inc.
2
| Private Company | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Galya Blachman
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Enliven Therapeutics, Inc. /US/
 Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology EnLiven Therapeutics, Inc. engages in the discovery and development of small molecule treatments for cancer. The company was founded by Samuel S. Kintz and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Founder Founder Founder Director/Board Member | |
| Stanford University | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree Masters Business Admin Doctorate Degree | |
| Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Doctorate Degree Graduate Degree Doctorate Degree Doctorate Degree | |
Purigen Biosystems, Inc.
 Purigen Biosystems, Inc. BiotechnologyHealth Technology Purigen Biosystems, Inc. engages in extracting, enriching and quantifying DNA and RNA from biological samples. The company was founded in 2012 by Amy Hiddessen, Klint Rose and Juan Santiago and is headquartered in Pleasanton, CA. | Biotechnology | Director/Board Member Director/Board Member Chairman Director/Board Member | |
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Graduate Degree Undergraduate Degree Doctorate Degree Graduate Degree | |
Precision NanoSystems, Inc.
 Precision NanoSystems, Inc. Electronic Equipment/InstrumentsElectronic Technology Precision NanoSystems, Inc. manufactures equipment related to testing electricity and electrical Signals. It develops tools and processes for the development and manufacture of nanoparticles for use as medicines and in medical research. The company was founded by Robert James Taylor and Euan Ramsay in 2010 and is headquartered in Vancouver, Canada. | Electronic Equipment/Instruments | Director/Board Member Chairman Director/Board Member Chairman | |
| CINCOR PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member | |
| University of California, Berkeley | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| VOR BIOPHARMA INC. | Biotechnology | Chairman Chief Executive Officer Director/Board Member | |
Ilypsa, Inc.
 Ilypsa, Inc. BiotechnologyHealth Technology Ilypsa, Inc. operates a biopharmaceutical firm. It develops renal care pharmaceutical products. The company was founded on March 6, 2003 and is headquartered in Thousand Oaks, CA. | Biotechnology | Chairman Director/Board Member Corporate Officer/Principal | |
Cleave Therapeutics, Inc.
 Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| IDEAYA BIOSCIENCES, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Director of Finance/CFO | |
RareCyte, Inc.
 RareCyte, Inc. Medical SpecialtiesHealth Technology RareCyte Inc. develops life science research and diagnostic that focuses on characterizing and isolating rare cells in the blood. It engages in bringing its technology to the life sciences research, drug development and diagnostic markets providing new tools to answer difficult questions related to cancer and cardiovascular disease. It's ground-breaking sccuCyte system is an open platform for the unbiased discovery and isolation of circulating tumor cells and circulating endothelial cells from whole blood. The company was founded by Ronald Seubert in 2009 and is headquartered in Seattle, WA. | Medical Specialties | Director/Board Member Chief Executive Officer Director/Board Member | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Analyst Private Equity Analyst Private Equity Investor | |
| University of California, Los Angeles | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree | |
| RALLYBIO CORPORATION | Biotechnology | Founder Director/Board Member Director/Board Member | |
| Boston University | College/University | Undergraduate Degree Undergraduate Degree Director/Board Member | |
Rallybio LLC
 Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Rallybio LLC operates as a development-stage biotechnology company. The firm develops transformative therapies for patients. It focuses on bringing life-transforming medicines to patients with devastating and rare disorder. The company was founded by Martin Mackay, Stephen Uden and Jeffrey Fryer in 2018 and is headquartered in Farmington, CT. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member Director/Board Member | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Consultant / Advisor Corporate Officer/Principal | |
| EDITAS MEDICINE, INC. | Biotechnology | Corporate Officer/Principal Director/Board Member General Counsel | |
| The University of Edinburgh | College/University | Doctorate Degree Graduate Degree | |
Charm Therapeutics Ltd.
 Charm Therapeutics Ltd. BiotechnologyHealth Technology Charm Therapeutics Ltd. is a British London-based company that is discovering and developing small molecule medicines using its proprietary 3D deep learning-enabled platform, Dragonfold. The company aims to create life-changing therapies for difficult-to-drug targets in cancer and other disease areas. Charm Therapeutics has raised $70 million to date and is supported by high-quality international investors, including Orbimed, F-Prime Capital, General Catalyst, Khosla Ventures, Bristol Myers Squibb, NVIDIA, and Grep-VC. The company was founded in 2021 by Laksh Aithani and David Baker, with Laksh Aithani serving as the CEO since then. | Biotechnology | Director/Board Member Director/Board Member | |
| FLEXION THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Kinaset Therapeutics, Inc.
 Kinaset Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kinaset Therapeutics, Inc. engages in the provision of pharmaceutical services. It develops therapeutics for intractable diseases including severe asthma. The company was founded by Robert Clarke, Roger Heerman, and Frazer Morgan and is headquartered in Medfield, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| The Johns Hopkins University | College/University | Graduate Degree Undergraduate Degree | |
| Charm Therapeutics, Inc. | Director/Board Member Director/Board Member | ||
| The Boston Consulting Group | Consultant / Advisor Consultant / Advisor | ||
Modis Therapeutics, Inc.
 Modis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Modis Therapeutics, Inc. is a biopharmaceutical company, which develops disease-modifying therapies for rare genetic diseases. Its product MT1621 is in clinical development for thymidine kinase 2 deficiency (TK2d), an inherited mitochondrial disease. The company was founded by Peter H. Barber and Daniel D. DiPietro in 2016 and is headquartered in Oakland, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| ORIC PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree | |
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Investment Managers | Private Equity Investor Private Equity Investor | |
| The Rockefeller University | College/University | Graduate Degree Doctorate Degree | |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
Transcelerate Biopharma, Inc.
 Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Biotechnology | Director/Board Member Chairman | |
Westlake Biopartners LLC
 Westlake Biopartners LLC Investment ManagersFinance Westlake Biopartners LLC (Westlake Biopartners) is a venture capital firm founded in 2018. The firm is headquartered in Westlake Village, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
| Boston College | College/University | Undergraduate Degree Undergraduate Degree | |
SR One Capital Management LP
 SR One Capital Management LP Investment ManagersFinance SR One Capital Management LP (SR One) is a venture capital firm founded in 2020. The firm is headquartered in Redwood, California. | Investment Managers | Private Equity Investor Director/Board Member | |
Rallybio Holdings LLC
 Rallybio Holdings LLC Medical/Nursing ServicesHealth Services Rallybio Holdings LLC engages in the provision of healthcare services. The company is headquartered in New Haven, CT. | Medical/Nursing Services | Chief Executive Officer Director/Board Member | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Corporate Officer/Principal | |
| Imperial College London | College/University | Masters Business Admin Undergraduate Degree | |
Amunix Pharmaceuticals, Inc.
 Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Biotechnology | Chairman Chief Tech/Sci/R&D Officer | |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Chairman Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| AUDENTES THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Director/Board Member |
Statistik
International
| Vereinigte Staaten | 43 |
| Vereinigtes Königreich | 5 |
| Kanada | 2 |
| Israel | 2 |
| Mexiko | 2 |
Sektoral
| Health Technology | 24 |
| Consumer Services | 14 |
| Finance | 7 |
| Commercial Services | 3 |
| Health Services | 3 |
Operativ
| Director/Board Member | 337 |
| Corporate Officer/Principal | 149 |
| Independent Dir/Board Member | 88 |
| Undergraduate Degree | 88 |
| Private Equity Investor | 68 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Andrew Schwab | 45 |
| Richard Heyman | 33 |
| Scott Rocklage | 32 |
| Kush Parmar | 32 |
| John Diekman | 29 |
| Rishi Gupta | 29 |
| Martin MacKay | 28 |
| Jake Bauer | 24 |
| Andrew Phillips | 23 |
| Brian Daniels | 20 |
| Alexander Semenovich Vinokurov | 19 |
| Arthur Tzianabos | 15 |
| David Allison | 15 |
| Elliott Levy | 14 |
| Peter Kim | 14 |
- Börse
- Insiders
- Galya Blachman
- Unternehmensverbindungen
